IFN- -1a cost effective long term for multiple sclerosis

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.428, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IFN- -1a cost effective long term for multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Long Term Treatment of Multiple Sclerosis with Interferon- May Be Cost Effective

By Kendrick M.   Johnson K.I.  

PharmacoEconomics, Vol. 18, Iss. 1, 2000-07 ,pp. : 45-53

Adis International

Access to resources Recommend Favorite

Long-Term Cost Effectiveness of Interferon- -1a in the Treatment of Relapsing-Remitting Multiple Sclerosis: An Econometric Model

By Lepen C.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 571-581

Adis International

Access to resources Recommend Favorite

Patients with multiple sclerosis (MS) who receive interferon (IFN)- -1a [`Avonex']

By  

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Patients with multiple sclerosis (MS) who receive interferon (IFN)- -1a [`Avonex']

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 355, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite